risperidone has been researched along with lurasidone hydrochloride in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (61.11) | 24.3611 |
| 2020's | 7 (38.89) | 2.80 |
| Authors | Studies |
|---|---|
| Cucchiaro, J; Fox, KH; Harvey, PD; Keefe, RS; Loebel, A; Siu, C | 1 |
| Citrome, L; Cucchiaro, J; Loebel, A; Phillips, D; Sarma, K; Silva, R; Tsuchiya, S | 1 |
| Diefenderfer, LA; Iuppa, CA | 1 |
| Awad, G; Hassan, M; Hsu, J; Loebel, A; Pikalov, A; Rajagopalan, K | 1 |
| Morrissette, DA; Stahl, SM | 1 |
| Cornelius, V; Smith, L; Taylor, DM; Young, AH | 1 |
| Cucchiaro, J; Loebel, A; Mao, Y; Meyer, JM; Pikalov, A | 1 |
| Loebel, A; Meyer, N; Rajagopalan, K; Wade, S | 1 |
| Kou, C; Liu, X; Liu, Y; Ma, Y; Song, Y; Su, Y; Wang, M; Yang, G; You, Y; Zhang, L; Zhang, Y | 1 |
| Chen, HK; Chen, JY; Chen, TT; Chou, YH; Higuchi, T; Huang, SY; Ishigouoka, J; Iyo, M; Katoh, T; Kwon, JS; Lee, JS; Saeki, Y; Tanaka, H; Wang, TS; Wu, BJ | 1 |
| Huang, A; Loebel, A; Messali, A; Ng-Mak, D; Wang, L | 1 |
| Deng, W; Feng, Y; Li, K; Li, L; Liu, Q; Liu, X; Luo, X; Ning, Y; Shi, J; Tan, Y; Wang, G; Wang, L; Wang, X; Xie, S; Xu, X; Zhang, X; Zhao, J | 1 |
| Crippa, A; Davis, JM; Leucht, S; Orsini, N; Patel, MX; Siafis, S | 1 |
| Broder, MS; Chang, E; Greene, M; Houle, CR; Tarbox, MH; Waters, HC; Yan, T | 1 |
| Haddad, PM; Loebel, A; Mattingly, GW; Phillips, D; Pikalov, A; Tocco, M; Xu, J | 1 |
| Arango, C; Leucht, S; Lopez-Morinigo, JD | 1 |
| Cao, L; Liu, J; Wu, J | 1 |
| Butzbach, DM; Castle, JW; Costello, SP; Kirkbride, KP; Lenehan, CE; Reith, F; Walker, GS | 1 |
6 review(s) available for risperidone and lurasidone hydrochloride
| Article | Year |
|---|---|
Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Clozapine; Dibenzocycloheptenes; Drug Therapy, Combination; Heterocyclic Compounds, 4 or More Rings; Humans; Impulsive Behavior; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Polypharmacy; Psychotic Disorders; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Thiazoles; Violence | 2014 |
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lithium Compounds; Lurasidone Hydrochloride; Monoamine Oxidase Inhibitors; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles; Treatment Outcome; Triazines; Valproic Acid | 2014 |
The metabolic side effects of 12 antipsychotic drugs used for the treatment of schizophrenia on glucose: a network meta-analysis.
Topics: Antipsychotic Agents; Benzodiazepines; Blood Glucose; Humans; Insulin; Lurasidone Hydrochloride; Network Meta-Analysis; Olanzapine; Piperazines; Risperidone; Schizophrenia; Thiazoles | 2017 |
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Aripiprazole; Clozapine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Haloperidol; Humans; Imidazoles; Indoles; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Thiophenes | 2020 |
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Haloperidol; Humans; Lurasidone Hydrochloride; Molindone; Olanzapine; Paliperidone Palmitate; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Systematic Reviews as Topic | 2022 |
Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China.
Topics: Antipsychotic Agents; Aripiprazole; Cost-Benefit Analysis; Humans; Lurasidone Hydrochloride; Olanzapine; Risperidone; Schizophrenia | 2022 |
6 trial(s) available for risperidone and lurasidone hydrochloride
| Article | Year |
|---|---|
Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial.
Topics: Adult; Antipsychotic Agents; Cognition Disorders; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles | 2011 |
Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study.
Topics: Adult; Ambulatory Care; Analysis of Variance; Antipsychotic Agents; Croatia; Double-Blind Method; Female; Humans; Isoindoles; Israel; Kaplan-Meier Estimate; Lurasidone Hydrochloride; Male; Middle Aged; Proportional Hazards Models; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; South Africa; South America; Thailand; Thiazoles; Time Factors; Treatment Outcome; United States | 2012 |
Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Drug Substitution; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Olanzapine; Outpatients; Piperazines; Quality of Life; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2014 |
Randomized, double-blind, placebo, and risperidone-controlled study of lurasidone in the treatment of schizophrenia: Results of an inconclusive 6-week trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Female; Humans; Lurasidone Hydrochloride; Male; Middle Aged; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2019 |
Randomized, double-blind, 6-week non-inferiority study of lurasidone and risperidone for the treatment of schizophrenia.
Topics: Adult; Antipsychotic Agents; China; Double-Blind Method; Female; Humans; Lurasidone Hydrochloride; Male; Middle Aged; Outcome Assessment, Health Care; Risperidone; Schizophrenia; Young Adult | 2020 |
Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study.
Topics: Adult; Antipsychotic Agents; Double-Blind Method; Female; Humans; Lurasidone Hydrochloride; Male; Metabolic Syndrome; Risperidone; Schizophrenia; Time Factors; Treatment Outcome | 2020 |
6 other study(ies) available for risperidone and lurasidone hydrochloride
| Article | Year |
|---|---|
Risperidone-induced Pisa syndrome in MS: resolution with lurasidone and recurrence with Chlorpromazine.
Topics: Adult; Antipsychotic Agents; Child Development Disorders, Pervasive; Chlorpromazine; Gait Ataxia; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Multiple Sclerosis; Recurrence; Risperidone; Syndrome; Thiazoles | 2013 |
Weight change during long-term treatment with lurasidone: pooled analysis of studies in patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Body Mass Index; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Lurasidone Hydrochloride; Male; Middle Aged; Observational Studies as Topic; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Time Factors; Weight Gain; Young Adult | 2015 |
Real-world adherence assessment of lurasidone and other oral atypical antipsychotics among patients with schizophrenia: an administrative claims analysis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Humans; Insurance Claim Review; Lurasidone Hydrochloride; Male; Medicaid; Medication Adherence; Middle Aged; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; United States | 2017 |
Hospitalization risk in patients with schizophrenia treated with dose-equivalent antipsychotics.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Female; Hospitalization; Humans; Lurasidone Hydrochloride; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia | 2019 |
Health Care Cost in Patients With Schizophrenia Treated With Brexpiprazole Versus Other Oral Atypical Antipsychotic Therapy.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Female; Health Care Costs; Hospitalization; Humans; Lurasidone Hydrochloride; Male; Medicaid; Medicare; Middle Aged; Olanzapine; Paliperidone Palmitate; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Thiophenes; United States | 2020 |
Microbial degradation products of lurasidone and their significance in postmortem toxicology.
Topics: Forensic Toxicology; Humans; Lurasidone Hydrochloride; Retrospective Studies; Risperidone; Tandem Mass Spectrometry | 2023 |